Profil
Kimberley S.
Gannon worked as a Senior Director-Biology at Predix Pharmaceuticals, Inc., Senior VP-Preclinical Research & Development at Proclara Biosciences, Inc., Vice President-Research & Development at Ischemix, Inc., Head-US Operations at Eolas Biosciences Co., Ltd., and Chief Scientific Officer at Lysogene SA. She received a doctorate degree from Florida State University in 1994.
Tidigare kända positioner av Kimberley S. Gannon
| Företag | Position | Slut |
|---|---|---|
| LYSOGENE | Teknisk/Vetenskaplig/F&U Direktör | 2018-05-02 |
Eolas Biosciences Co., Ltd. | Företagsledare/Principal | - |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs | Företagsledare/Principal | - |
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Företagsledare/Principal | - |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Provides treatment of chronic neurodegenerative diseases | Teknisk/Vetenskaplig/F&U Direktör | - |
Kimberley S. Gannons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Health Technology |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Provides treatment of chronic neurodegenerative diseases | Health Technology |
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs | Health Technology |
Eolas Biosciences Co., Ltd. | |
Lysogene SA
Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
















